<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Few cases of secondary CD5+ diffuse large B-cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DLBCL</z:e>) that are not Richter syndrome have been reported previously </plain></SENT>
<SENT sid="1" pm="."><plain>We report 9 cases of non-Richter syndrome secondary CD5+ <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DLBCL</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>Among 529 cases of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DLBCL</z:e>, 38 (7.2%) were CD5+ <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DLBCL</z:e>, including 9 of secondary CD5+ <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DLBCL</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>Five cases gained CD5 expression during the clinical course of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DLBCL</z:e> (group 1) </plain></SENT>
<SENT sid="4" pm="."><plain>Three cases showed transformation from CD5- low-grade B-cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> to CD5+ <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DLBCL</z:e> (group 2) </plain></SENT>
<SENT sid="5" pm="."><plain>The remaining case showed coexistence of CD5+ <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DLBCL</z:e> and CD5+ follicular <z:hpo ids='HP_0002665'>lymphoma</z:hpo> </plain></SENT>
<SENT sid="6" pm="."><plain>The clonal relationships of CD5- and CD5+ <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> were confirmed in <z:hpo ids='HP_0000001'>all</z:hpo> 4 available cases </plain></SENT>
<SENT sid="7" pm="."><plain>Cases of secondary CD5+ <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DLBCL</z:e> that were not Richter syndrome were classifiable into 3 groups </plain></SENT>
<SENT sid="8" pm="."><plain>Groups 1 and 2 showed the gain of CD5 during the clinical course or transformation of the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e>, suggesting that CD5 expression is closely associated with the progression of B-cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> </plain></SENT>
</text></document>